Related to NOVEL CANCER THERAPY MAY ARISE FROM DWARF POPULATION STUDY

• Bayer Schering Pharma Receives Chinese Approval for MS Drug and Signs Anticancer Deal with Micromet
  
• Cyntellect and Boston University Ink Partnership to Research Diabetes and Anemia
  
• Researchers Awarded $2.4M to Study Neuronal Regeneration
  
• Pfizer and Crown Team Up to Develop Treatments for Asian Cancers
  
• Researchers Provide Systems-Level Dissection of Regulatory Perturbations in Cancer
  
• Ludwig Institute to Evaluate Pro-Pharmaceuticals’ Candidate for Its Ability to Enhance Antitumor T Cells
  
• Teva Buys OncoGenex' Late-Stage Anticancer Agent with $110M in Payments
  
• Scientists Use New Mouse Model to Visualize Metastasis Formation in Real Time
  
• Aura to Use CRT's Cancer-Targeting Peptides for Delivery
  
• Scientists Discover that Circulating Tumor Cells Can Return to Their Original Site
  
• Researchers Identify Protein that Inhibits Tumor-Targeting Immune Cells When Activated
  
• Dicerna and Kyowa Hakko Kirrin Ally on Cancer Drug R&D
  
• Horizon Sets Up Subsidiary to Exploit Isogenic Cell-Line Technology for Companion Diagnostics
  
• Oncomed to Exploit Fluidigm’s Microfluidic Devices in Cancer Stem Cell Research
  
• Ferrer InCode to Market BioTheranostics’ Cancer Classification Assay in Four Countries
  
• VentiRx Pockets $25M to Fund Clinical Development of TLR8 Candidates
  
• Scientists May Have Discovered Why Some Anticancer Agents Cause Heart Failure
  
• Boehringer Ingelheim and Priaxon Ally on Cancer Drug R&D
  
• Formatech to Fill and Finish One Lot of ViroMed’s Preclinical Cancer Vaccine at No Charge
  
• Sage and Pfizer Team Up on Cancer Research